US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

PIMCO DYNAMIC INCOME STRATEGY FUND

21.84

+0.02000.09%

Post-market: 21.840.00000.00%16:10 EDT

Volume:85.94K

Turnover:1.88M

Market Cap:976.40M

PE:4.11

High:21.94

Open:21.94

Low:21.79

Close:21.82

52wk High:25.21

52wk Low:18.47

Shares:44.71M

Float Shares:44.71M

Volume Ratio:1.01

T/O Rate:0.19%

Dividend:4.57

Dividend Rate:20.93%

EPS(TTM):5.31

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Press Release: BioLineRx Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Propanc Biopharma Announces Compelling New Preclinical Pancreatic Cancer Data for PRP Showing >90% Tumor Growth Inhibition and >2.5-Fold Survival Benefit

Pimco Portfolio Manager Greg Elliot Sharenow Buys $131,030 of Pimco Dynamic Income Strategy Fund Common Shares

Saba Capital Management Disposes of $291,530 Pimco Dynamic Income Strategy Fund Shares

Propanc Biopharma Highlights Differentiated Proenzyme Therapy PRP as a Potential Therapy of Choice Against RAS-Driven Cancers

PIMCO Executive Committee Member Thibault Christian Stracke Acquires PIMCO Dynamic Income Strategy Fund Common Shares Worth $540,468‬

Propanc Biopharma Announces Positive Preclinical and Early Translational Data for PRP Showing >90% Tumor Growth Inhibition and Significant Survival Benefit in Pancreatic Ductal Adenocarcinoma Models

Press Release: PIMCO Closed-End Funds Declare Monthly Common Share Distributions

Pimco Dynamic Income Strategy Fund Files Initial Beneficial Ownership Statement for Assistant Treasurer Paul Vitale

Press Release: PIMCO Closed-end Funds Declare Monthly Common Share Distributions

Press Release: BioLineRx Reports First Quarter 2026 Financial Results and Provides Corporate Update

PIMCO portfolio manager Greg Elliot Sharenow buys USD 385,769 Pimco Dynamic Income Strategy Fund shares

Pimco portfolio manager Greg Elliot Sharenow buys PIMCO Dynamic Income Strategy Fund shares for $107,630

Pimco Dynamic Income Strategy Fund announces shareholder meeting

Press Release: PIMCO Closed-End Funds Declare Monthly Common Share Distributions

PIMCO portfolio manager Daniel J. Ivascyn buys $592,327 Pimco Dynamic Income Strategy Fund shares

Transcenta Therapeutics Presents New Data for its Novel LIV1-Targeting ADC TST013 Demonstrating Potent Anti-Tumor Activity in PDX Models of Prostate Cancer and ER Positive /HER2 Negative Breast Cancer

TRANSCENTA-B Reveals New Data Showing Potent Anti-Tumor Activity of Novel LIV1 ADC TST013 in Prostate Cancer and ER-Positive/HER2-Negative Breast Cancer PDX Models

Nurix Therapeutics Announces New Preclinical Data Highlighting Breadth of Targeted Protein Degradation Pipeline at AACR 2026

Avacta data at AACR 2026 underline favorable profile of AVA6103 and advantages of pre|CISION® delivery platform

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/stock/PDX/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PDX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PDX\",,,,,undefined,":{"symbol":"PDX","market":"US","secType":"STK","nameCN":"PIMCO DYNAMIC INCOME STRATEGY FUND","latestPrice":21.84,"timestamp":1788292800000,"preClose":21.82,"halted":0,"volume":85942,"hourTrading":{"tag":"盘后","latestPrice":21.84,"preClose":21.84,"latestTime":"16:10 EDT","volume":9,"amount":196.56,"timestamp":1788293404937,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.0009165902841429685,"floatShares":44706949,"shares":44706949,"eps":5.31,"marketStatus":"Post-Mkt","change":0.02,"latestTime":"09-01 17:22:26 EDT","open":21.94,"high":21.94,"low":21.785,"amount":1880456,"amplitude":0.007104,"askPrice":23.59,"askSize":3000,"bidPrice":21,"bidSize":50,"shortable":3,"etf":0,"ttmEps":5.31,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1788307200000},"marketStatusCode":4,"adr":0,"listingDate":1548824400000,"exchange":"NYSE","adjPreClose":21.82,"dividendRate":0.209309,"preHourTrading":{"tag":"盘前","latestPrice":22.46,"preClose":21.82,"latestTime":"04:00 EDT","volume":1,"amount":22.46,"timestamp":1788249605221,"change":0.64,"changeRate":0.029331,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":21.84,"preClose":21.84,"latestTime":"16:10 EDT","volume":9,"amount":196.56,"timestamp":1788293404937,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.014771},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PDX\",,,,,undefined,":{"symbol":"PDX","floatShares":44706949,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.014771,"shares":44706949,"dividePrice":4.5713,"high":21.94,"amplitude":0.007104,"preClose":21.82,"low":21.785,"week52Low":18.47,"pbRate":"--","week52High":25.21,"institutionHeld":0,"latestPrice":21.84,"committee":-0.967213,"eps":5.31,"divideRate":0.209309,"volume":85942,"delay":0,"ttmEps":5.31,"open":21.94,"prevYearClose":18.78,"prevWeekClose":21.66,"prevMonthClose":21.82,"prevQuarterClose":20.82,"fiveDayClose":21.67,"twentyDayClose":21.6,"sixtyDayClose":21.25},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PDX\",params:#limit:5,,,undefined,":[{"date":"2026-08-13","symbol":"PDX","amount":0.1334,"announcedDate":"2026-08-03","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-08-13","defaultRemindTime":1786627800000,"name":"PIMCO DYNAMIC INCOME STRATEGY FUND","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-09-01","payableDate":"2026-08-13","currency":"USD","dateTimestamp":1786593600000,"payDate":"2026-09-01"},{"date":"2026-07-13","symbol":"PDX","amount":0.1334,"announcedDate":"2026-07-01","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-07-13","defaultRemindTime":1783949400000,"name":"PIMCO DYNAMIC INCOME STRATEGY FUND","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-08-03","payableDate":"2026-07-13","currency":"USD","dateTimestamp":1783915200000,"payDate":"2026-08-03"},{"date":"2026-06-11","symbol":"PDX","amount":0.1334,"announcedDate":"2026-06-01","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-11","defaultRemindTime":1781184600000,"name":"PIMCO DYNAMIC INCOME STRATEGY FUND","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-07-01","payableDate":"2026-06-11","currency":"USD","dateTimestamp":1781150400000,"payDate":"2026-07-01"},{"date":"2026-05-11","symbol":"PDX","amount":0.1334,"announcedDate":"2026-05-01","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-05-11","defaultRemindTime":1778506200000,"name":"PIMCO DYNAMIC INCOME STRATEGY FUND","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-01","payableDate":"2026-05-11","currency":"USD","dateTimestamp":1778472000000,"payDate":"2026-06-01"},{"date":"2026-04-13","symbol":"PDX","amount":0.1334,"announcedDate":"2026-04-01","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-04-13","defaultRemindTime":1776087000000,"name":"PIMCO DYNAMIC INCOME STRATEGY FUND","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-05-01","payableDate":"2026-04-13","currency":"USD","dateTimestamp":1776052800000,"payDate":"2026-05-01"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PDX\",market:\"US\",,,undefined,":[{"executeDate":"2023-12-08","recordDate":"2023-12-11","paymentDate":"2024-01-02","value":0.22,"currency":"USD"},{"executeDate":"2024-03-08","recordDate":"2024-03-11","paymentDate":"2024-04-01","value":0.26,"currency":"USD"},{"executeDate":"2024-04-10","recordDate":"2024-04-11","paymentDate":"2024-05-01","value":0.1133,"currency":"USD"},{"executeDate":"2024-05-10","recordDate":"2024-05-13","paymentDate":"2024-06-03","value":0.1133,"currency":"USD"},{"executeDate":"2024-06-13","recordDate":"2024-06-13","paymentDate":"2024-07-01","value":0.1133,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PDX\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PDX\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2663077540","title":"Press Release: BioLineRx Reports Second Quarter 2026 Financial Results and Provides Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2663077540","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663077540?lang=en_us&edition=fundamental","pubTime":"2026-08-31 19:00","pubTimestamp":1788174000,"startTime":"0","endTime":"0","summary":"maintaining its cash runway guidance into the first half of 2027.-- On August 27, 2026, the Company entered into a definitive agreement for. an offering with gross proceeds of $3.75 million, expected to close on or. about August 31, 2026.Development UpdatesGLIX1 in GBM-- In July, dosing commenced in the second of five planned cohorts in the. Phase 1 dose escalation part of the Phase 1/2a study.-- Three leading cancer centers are enrolling patients in the Phase 1. part of the study: NYU Langone Health, led by Dr. Alexandra. Miller; Northwestern University, led by Dr. Roger Stupp and Dr.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4567","BK4211","LU2211817866.USD","LU0347712357.USD","BK4195","BK4533","BK4585","BK4548","LU1093756168.USD","IE00B5TLWC47.USD","LU2413666699.HKD","BK4139","BK4121","BK4588","MTD","IE00BFXG0V08.USD","LU1093756325.SGD","BLRX","LU2413666426.HKD","LU1721428933.USD","PFS","PDX","IE00BYQQ9H92.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662859540","title":"Propanc Biopharma Announces Compelling New Preclinical Pancreatic Cancer Data for PRP Showing >90% Tumor Growth Inhibition and >2.5-Fold Survival Benefit","url":"https://stock-news.laohu8.com/highlight/detail?id=2662859540","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662859540?lang=en_us&edition=fundamental","pubTime":"2026-08-27 20:30","pubTimestamp":1787833800,"startTime":"0","endTime":"0","summary":"Differentiated Profile versus RAS-Targeted Approaches Including Revolution Medicines’ DaraxonrasibMELBOURNE, Australia, Aug.  27, 2026 (GLOBE NEWSWIRE) -- Propanc Biopharma, Inc. (Nasdaq: PPCB) (“Prop","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/27/3352011/0/en/propanc-biopharma-announces-compelling-new-preclinical-pancreatic-cancer-data-for-prp-showing-90-tumor-growth-inhibition-and-2-5-fold-survival-benefit.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ONG","BK4141","LU1720051017.SGD","IE00BFMHRM44.USD","LU1861214812.USD","LU2357305700.SGD","IE00BD6J9T35.USD","IE00BZ199S13.USD","LU1978683503.SGD","LU1854104046.USD","LU1854103824.USD","LU2298322129.HKD","LU1861220033.SGD","BK4605","LU1720051108.HKD","LU0724618433.USD","LU1983260115.SGD","BK4512","ON","LU1861219969.SGD","LU2360107325.USD","PDX","LU0348723411.USD","LU0124384867.USD","BK4585","BK4588","ONX","LU1861215975.USD","LU1548497426.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661373122","title":"Pimco Portfolio Manager Greg Elliot Sharenow Buys $131,030 of Pimco Dynamic Income Strategy Fund Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2661373122","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661373122?lang=en_us&edition=fundamental","pubTime":"2026-08-21 04:52","pubTimestamp":1787259122,"startTime":"0","endTime":"0","summary":"Pimco portfolio manager Greg Elliot Sharenow buys $131,030 of Pimco Dynamic Income Strategy Fund common sharesPimco Dynamic Income Strategy Fund portfolio manager Greg Elliot Sharenow bought 6,020 com","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nNDL2RyhpF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PDX","PDI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660280514","title":"Saba Capital Management Disposes of $291,530 Pimco Dynamic Income Strategy Fund Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2660280514","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660280514?lang=en_us&edition=fundamental","pubTime":"2026-08-19 20:27","pubTimestamp":1787142438,"startTime":"0","endTime":"0","summary":"Saba Capital Management disposes of $291,530 Pimco Dynamic Income Strategy Fund sharesSaba Capital Management sold 13,396 shares of Pimco Dynamic Income Strategy Fund common stock on Aug. 18, 2026 at ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260819:nNDLcQBJ7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PDX","PDI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658086429","title":"Propanc Biopharma Highlights Differentiated Proenzyme Therapy PRP as a Potential Therapy of Choice Against RAS-Driven Cancers","url":"https://stock-news.laohu8.com/highlight/detail?id=2658086429","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658086429?lang=en_us&edition=fundamental","pubTime":"2026-08-12 20:30","pubTimestamp":1786537800,"startTime":"0","endTime":"0","summary":"Contrasting Science with Revolution Medicines and ErascaMELBOURNE, Australia, Aug.  12, 2026 (GLOBE NEWSWIRE) -- Propanc Biopharma, Inc. (Nasdaq: PPCB) (“Propanc” or the “Company”), a biopharmaceutica","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/12/3343641/0/en/propanc-biopharma-highlights-differentiated-proenzyme-therapy-prp-as-a-potential-therapy-of-choice-against-ras-driven-cancers.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4142","IE00B4R5TH58.HKD","IE00BFTCPJ56.SGD","LU1861215975.USD","BK4585","LU0109394709.USD","LU1854104046.USD","LU0889565916.HKD","LU1983260115.SGD","LU0320765992.SGD","IE00B2B36J28.USD","LU2360107325.USD","LU0348723411.USD","BK4539","LU1854103824.USD","IE00BJT1NW94.SGD","PTH","LU1720051108.HKD","BK4512","LU1978683503.SGD","CHH","LU1861214812.USD","IE00BFMHRM44.USD","LU0724618433.USD","IE0009354923.USD","LU2298322129.HKD","BBH","ERAS","CANC","IE00BD6J9T35.USD","IE0002141913.USD","BK4605","LU0124384867.USD","LU2357305700.SGD","BK4588","IDNA","LU1861220033.SGD","RVMD","IE00BJJMRZ35.SGD","LU1720051017.SGD","BK4141","LU1861219969.SGD","ON","IE0009355771.USD","PDX","LU1548497426.USD","IE00BZ199S13.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658950603","title":"PIMCO Executive Committee Member Thibault Christian Stracke Acquires PIMCO Dynamic Income Strategy Fund Common Shares Worth $540,468‬","url":"https://stock-news.laohu8.com/highlight/detail?id=2658950603","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658950603?lang=en_us&edition=fundamental","pubTime":"2026-08-11 07:27","pubTimestamp":1786404421,"startTime":"0","endTime":"0","summary":"PIMCO executive committee member Thibault Christian Stracke acquires PIMCO Dynamic Income Strategy Fund common shares worth $540,468Thibault Christian Stracke, a member of Pimco’s Executive Committee,","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nNDL2Dqp4k:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PDI","PDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657634844","title":"Propanc Biopharma Announces Positive Preclinical and Early Translational Data for PRP Showing >90% Tumor Growth Inhibition and Significant Survival Benefit in Pancreatic Ductal Adenocarcinoma Models","url":"https://stock-news.laohu8.com/highlight/detail?id=2657634844","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657634844?lang=en_us&edition=fundamental","pubTime":"2026-08-06 20:30","pubTimestamp":1786019400,"startTime":"0","endTime":"0","summary":"Accelerates Phase 1b First-in-Human Trial TimelineMELBOURNE, Australia, Aug.  06, 2026  (GLOBE NEWSWIRE) -- Propanc Biopharma, Inc. (Nasdaq: PPCB) (“Propanc” or the “Company”), a biopharmaceutical com","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/06/3340282/0/en/Propanc-Biopharma-Announces-Positive-Preclinical-and-Early-Translational-Data-for-PRP-Showing-90-Tumor-Growth-Inhibition-and-Significant-Survival-Benefit-in-Pancreatic-Ductal-Adeno.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656302546","title":"Press Release: PIMCO Closed-End Funds Declare Monthly Common Share Distributions","url":"https://stock-news.laohu8.com/highlight/detail?id=2656302546","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656302546?lang=en_us&edition=fundamental","pubTime":"2026-08-04 04:46","pubTimestamp":1785789960,"startTime":"0","endTime":"0","summary":"NEW YORK----August 03, 2026--The Boards of Trustees/Directors of the PIMCO closed-end funds below  have declared a monthly distribution for each Fund's common shares as summarized below.For the following Funds, the distributions are payable on September 1, 2026 to shareholders of record on August 13, 2026, with an ex-dividend date of August 13, 2026:Monthly Distribution. Fund              NYSE Symbol    Amount     Previous Month    Previous Month","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PDX","PGP","RCS","PFL","PTY","PAXS","PCM","PCN","PNI","PDI","PCQ","PHK","PML","PFN","PDO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650911545","title":"Pimco Dynamic Income Strategy Fund Files Initial Beneficial Ownership Statement for Assistant Treasurer Paul Vitale","url":"https://stock-news.laohu8.com/highlight/detail?id=2650911545","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650911545?lang=en_us&edition=fundamental","pubTime":"2026-07-09 06:46","pubTimestamp":1783550793,"startTime":"0","endTime":"0","summary":"Pimco Dynamic Income Strategy Fund files initial beneficial ownership statement for Assistant Treasurer Paul VitalePIMCO Dynamic Income Strategy Fund filed a Form 3 naming Paul Vitale as assistant tre","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260708:nNDL4Y0290:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648522365","title":"Press Release: PIMCO Closed-end Funds Declare Monthly Common Share Distributions","url":"https://stock-news.laohu8.com/highlight/detail?id=2648522365","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648522365?lang=en_us&edition=fundamental","pubTime":"2026-07-02 07:04","pubTimestamp":1782947040,"startTime":"0","endTime":"0","summary":"NEW YORK----July 01, 2026--The Boards of Trustees/Directors of the PIMCO closed-end funds below  have declared a monthly distribution for each Fund's common shares as summarized below.For the following Funds, the distributions are payable on August 3, 2026 to shareholders of record on July 13, 2026, with an ex-dividend date of July 13, 2026:Monthly Distribution Per Share. Fund               NYSE Symbol    Amount     Previous Month   Previous Month","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PFL","PCM","PAXS","PCQ","PGP","PNI","PTY","PDO","PML","PHK","PFN","PDI","RCS","PCN","PDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638048955","title":"Press Release: BioLineRx Reports First Quarter 2026 Financial Results and Provides Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2638048955","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638048955?lang=en_us&edition=fundamental","pubTime":"2026-05-27 19:00","pubTimestamp":1779879600,"startTime":"0","endTime":"0","summary":"- Announced first patient dosed in Phase 1/2a clinical trial of GLIX1 for treatment of glioblastoma  -. - Announced new GLIX1 data demonstrating potent anti-tumor effect in GBM across multiple in-vivo studies, including a temozolomide -resistant patient-derived xenograft model -. - Management to host conference call today, May 27, at 8:30 am EDT -. TEL AVIV, Israel, May 27, 2026 /PRNewswire/ -- BioLineRx Ltd.  , a clinical-stage biopharmaceutical company pursuing life-changing therapies in oncology and rare diseases, today reported its unaudited financial results for the quarter ended March 31, 2026, and provided a corporate update.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B5TLWC47.USD","BK4588","CDX","BK4533","BK4567","MTD","PFS","BLRX","BK4121","PDX","LU1721428933.USD","BK4195","BK4211","LU2211817866.USD","LU2413666699.HKD","LU1093756168.USD","R","IE00BFXG0V08.USD","BK4139","LU1093756325.SGD","BK4232","IE00BYQQ9H92.USD","LU2413666426.HKD","BK4022","BK4585","LU0347712357.USD","BK4548"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637350495","title":"PIMCO portfolio manager Greg Elliot Sharenow buys USD 385,769 Pimco Dynamic Income Strategy Fund shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2637350495","media":"Reuters","labels":["insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637350495?lang=en_us&edition=fundamental","pubTime":"2026-05-22 06:27","pubTimestamp":1779402472,"startTime":"0","endTime":"0","summary":"Greg Elliot Sharenow, portfolio manager, reported open-market purchases of Pimco Dynamic Income Strategy Fund common shares.He added 17,819 shares at weighted average prices of $21.66, $21.63.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pimco Dynamic Income Strategy Fund published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 21, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260521:nNDLRcblK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"PIMCO portfolio manager Greg Elliot Sharenow buys USD 385,769 Pimco Dynamic Income Strategy Fund shares","news_tag":"insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636800290","title":"Pimco portfolio manager Greg Elliot Sharenow buys PIMCO Dynamic Income Strategy Fund shares for $107,630","url":"https://stock-news.laohu8.com/highlight/detail?id=2636800290","media":"Reuters","labels":["insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636800290?lang=en_us&edition=fundamental","pubTime":"2026-05-19 07:02","pubTimestamp":1779145360,"startTime":"0","endTime":"0","summary":"Greg Elliot Sharenow, portfolio manager, reported buying 5,000 Pimco Dynamic Income Strategy Fund common shares at USD 21.53.Directly held common shares rose to 26,285 following the purchase.He also reported indirect ownership of 34,051 common shares held by DCP.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pimco Dynamic Income Strategy Fund published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 18, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260518:nNDLBBJbh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PDI","PDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635675871","title":"Pimco Dynamic Income Strategy Fund announces shareholder meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2635675871","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635675871?lang=en_us&edition=fundamental","pubTime":"2026-05-14 04:08","pubTimestamp":1778702916,"startTime":"0","endTime":"0","summary":"Pimco Dynamic Income Strategy Fund will hold annual shareholder meeting in Newport Beach, California, on June 26, 2026.Shareholders will vote on election of Mark Michel and Sonya Morris as trustees.Ballot also covers re-election of Libby D. Cantrill as trustee.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pimco Dynamic Income Strategy Fund published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 13, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260513:nNDL2YgBzT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632623359","title":"Press Release: PIMCO Closed-End Funds Declare Monthly Common Share Distributions","url":"https://stock-news.laohu8.com/highlight/detail?id=2632623359","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632623359?lang=en_us&edition=fundamental","pubTime":"2026-05-02 05:57","pubTimestamp":1777672620,"startTime":"0","endTime":"0","summary":"The Boards of Trustees/Directors of the PIMCO closed-end funds below  have declared a monthly distribution for each Fund's common shares as summarized below.For the following Funds, the distributions are payable on June 1, 2026 to shareholders of record on May 11, 2026, with an ex-dividend date of May 11, 2026:. Fund               NYSE Symbol    Amount     Previous Month   Previous Month","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PCM","PDI","BK4600","MSTY","MSTU","MSTW","PDO","PDX","PHK","BK4595","MSTZ","PTY","3SMI.UK","MST","MTYY","SMI3.UK","MSDD","BK4023","BK4588","3LMI.UK","07799","PAXS","MSST","APED","09399","PML","BK4232","07399","PNI","SMST","MSTK","PCQ","PFL","MSII","MSTP","PFN","LMI3.UK","BK4585","MSTX","09799","BK4022","IMST","PGP","BK4596","MSTY.UK","MSOO","PCN","BK4516","RCS","WNTR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631204415","title":"PIMCO portfolio manager Daniel J. Ivascyn buys $592,327 Pimco Dynamic Income Strategy Fund shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2631204415","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631204415?lang=en_us&edition=fundamental","pubTime":"2026-04-30 06:35","pubTimestamp":1777502105,"startTime":"0","endTime":"0","summary":"Daniel J. Ivascyn, PIMCO Executive Committee member and portfolio manager, reported a purchase of 28,779 Pimco Dynamic Income Strategy Fund common shares at USD 20.58 each.Directly held stake rose to 2.12 million shares following the transaction.Indirect holdings via trust were reported at 79,534 shares.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pimco Dynamic Income Strategy Fund published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 29, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260429:nNDL68rjV9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"PIMCO portfolio manager Daniel J. Ivascyn buys $592,327 Pimco Dynamic Income Strategy Fund shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629833979","title":"Transcenta Therapeutics Presents New Data for its Novel LIV1-Targeting ADC TST013 Demonstrating Potent Anti-Tumor Activity in PDX Models of Prostate Cancer and ER Positive /HER2 Negative Breast Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2629833979","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629833979?lang=en_us&edition=fundamental","pubTime":"2026-04-23 19:00","pubTimestamp":1776942000,"startTime":"0","endTime":"0","summary":"PRINCETON, N.J. and SUZHOU, China, April  23, 2026 (GLOBE NEWSWIRE) -- Transcenta Therapeutics (HKEX: 06628), a global clinical stage biopharmaceutical company with fully-integrated capabilities in di","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/23/3279725/0/en/Transcenta-Therapeutics-Presents-New-Data-for-its-Novel-LIV1-Targeting-ADC-TST013-Demonstrating-Potent-Anti-Tumor-Activity-in-PDX-Models-of-Prostate-Cancer-and-ER-Positive-HER2-Neg.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADC","LENZ","PDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1187613037","title":"TRANSCENTA-B Reveals New Data Showing Potent Anti-Tumor Activity of Novel LIV1 ADC TST013 in Prostate Cancer and ER-Positive/HER2-Negative Breast Cancer PDX Models","url":"https://stock-news.laohu8.com/highlight/detail?id=1187613037","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1187613037?lang=en_us&edition=fundamental","pubTime":"2026-04-23 07:06","pubTimestamp":1776899191,"startTime":"0","endTime":"0","summary":"TRANSCENTA-B (06628) announced the presentation of preclinical data for its self-developed LIV1 Antibody-Drug Conjugate (ADC) at the 2026 AACR Annual Meeting. The data demonstrated potent anti-tumor...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4080","BK1161","ADC","BK1574","159938","BK4231","09939","PDX","BK1515","06628"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629830048","title":"Nurix Therapeutics Announces New Preclinical Data Highlighting Breadth of Targeted Protein Degradation Pipeline at AACR 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2629830048","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629830048?lang=en_us&edition=fundamental","pubTime":"2026-04-22 19:00","pubTimestamp":1776855600,"startTime":"0","endTime":"0","summary":"Data showcase advances across oncology pipeline including pan-mutant BRAF, CBL-B and AURKA programs Presentations reinforce potential of degraders to overcome limitations of inhibitors and expand ther","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/22/3278794/0/en/Nurix-Therapeutics-Announces-New-Preclinical-Data-Highlighting-Breadth-of-Targeted-Protein-Degradation-Pipeline-at-AACR-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4135","BK4139","NRIX","CNS","PDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629362056","title":"Avacta data at AACR 2026 underline favorable profile of AVA6103 and advantages of pre|CISION® delivery platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2629362056","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629362056?lang=en_us&edition=fundamental","pubTime":"2026-04-22 00:00","pubTimestamp":1776787200,"startTime":"0","endTime":"0","summary":"Presentation of additional analyses from FAP-Exd (AVA6103) study shows robust activity in PDX models with low FAP expression and more favorable kinetic profile compared to the marketed antibody-drug c","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/21/3278250/0/en/Avacta-data-at-AACR-2026-underline-favorable-profile-of-AVA6103-and-advantages-of-pre-CISION-delivery-platform.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PDC","BK4218","CRC","PK","BK4231","PDX","BK4213","LU0456854461.SGD","BK4080","ADC","BK4181","LU0266512127.USD","BK4123"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":21,"code":"91000000","status":"200"}]}}